investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Risk Factors of Prostate Cancer in Sub Saharan Africa Populations
Dieudonne M Molamba
0 Collaborator(s)
Funding source
INSERM
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Risk Factors of Prostate Cancer in Sub Saharan Africa Populations
Related projects
Serigne Magueye
Ethnic Difference in Prostate Cancer
Prostate
Pathology
Katie E Hebron
Regulation of Prostate Cancer Progression by ALCAM Proteolysis
Prostate
Pathology
Bingcheng Wang
EphA2 kinase in prostate cancer
Prostate
Ah-Ng Tony Kong
Curcuma Longa: epigenetic effects in prostate and colon cancer
Prostate
Colorectum
Alastair Davies
A Cancer Stem Cell-Directed Therapy for Enzalutamide-Resistant Prostate Cancer
Prostate
Surgery / Surgical oncology
Charles L. Sawyers
Understanding Resistance to Next Generation Antiandrogens
Prostate
Catherine M. Tangen
PCPT and SELECT cohorts: Core Infrastructure Support for Cancer Research
Prostate
Clinton Kylie Matson
Exploiting the Genomic Programs Underlying AR-Independent Prostate Cancer
Prostate
Pathology
Deborah Enting
Influence of stage and therapy on the NKG2D axis in prostate cancer
Prostate